Qualification of the Analytical and Clinical Performance of CSF Biomarker Analyses in ADNI

Acta Neuropathologica - Germany
doi 10.1007/s00401-011-0808-0
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Clinical and Multimodal Biomarker Correlates of ADNI Neuropathological Findings

Acta neuropathologica communications
Forensic MedicineMolecular NeurosciencePathologyNeurologyCellular
2013English

The Qualification of an Enrichment Biomarker for Clinical Trials Targeting Early Stages of Parkinson’s Disease

Journal of Parkinson's Disease
Molecular NeuroscienceNeurologyCellular
2019English

Longitudinal Change in CSF Tau and Aβ Biomarkers for Up to 48 Months in ADNI

Acta Neuropathologica
Forensic MedicineMolecular NeurosciencePathologyNeurologyCellular
2013English

Improved Performance of CSF Dementia Biomarker Measurements Over Time: The Effect of Quality Control and Harmonization Programs

Biomarkers and Applications
2018English

Genome-Wide Association and Interaction Studies of CSF T-Tau/Aβ 42 Ratio in ADNI Cohort

Neurobiology of Aging
AgingGerontologyDevelopmental BiologyGeriatricsNeuroscienceNeurology
2017English

Protein Biomarker Identification in the CSF of Patients With CNS Lymphoma

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2008English

Building a Roadmap to Biomarker Qualification: Challenges and Opportunities

Biomarkers in Medicine
BiochemistryDrug DiscoveryClinical Biochemistry
2015English

Alzheimer's Disease Neuroimaging Initiative (ADNI): Clinical Characterization

Neurology
Neurology
2009English

Improving CSF Biomarker Accuracy in Predicting Prevalent and Incident Alzheimer Disease

Neurology
Neurology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy